ReviewCancer reports (Hoboken, N.J.)2021

SCR7, a potent cancer therapeutic agent and a biochemical inhibitor of nonhomologous DNA end-joining.

Meghana Manjunath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.